Mode
Text Size
Log in / Sign up
N/A N=64 Randomized Single-blind Treatment

Postoperative Telerehabilitation in Older Adults

Telerehabilitation · Carcinoma, Non-Small-Cell Lung · Cardiopulmonary Exercise Test

Enrolled (actual)
64
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcome: Primary: Change From Baseline in VO2 Peak (Peak Oxygen Uptake, mL/kg/Min) on the CardioPulmonary Exercise Test(CPET) After 4 Weeks Intervention — 23.67; 23.09; 19.28; 20.41 mL/kg/min

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Pulmonary Tele-Rehabilitation (Other); Control (Education) (Other)
Age
Older Adult · 65+ yrs
Sex
All
Sponsor
Pusan National University Hospital
Primary completion
Feb 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Change From Baseline in VO2 Peak (Peak Oxygen Uptake, mL/kg/Min) on the CardioPulmonary Exercise Test(CPET) After 4 Weeks Intervention
23.67; 23.09; 19.28; 20.41; 21.85; 19.85
SECONDARY
Ventilatory Efficiency (VE/VCO₂ Slope)
4.0; 0.6; -0.1; 1.4
SECONDARY
Maximal Inspiratory Pressure (MIP)
5.2; 8.3; 7.9; 5.4
SECONDARY
Skeletal Muscle Index (SMI)
0.1; -0.1; 0.1; 0.11
SECONDARY
Hospital Anxiety and Depression Scale (HADS)
-0.4; 0.6; -0.9; -0.1; -1.1; -0.6
SECONDARY
EQ-5D (EuroQol-5 Dimension)
0.05; -0.03; 0.05; 0.0; 6.4; 5.4
SECONDARY
Grip Strength
-0.3; 0.1; -0.7; -0.2
SECONDARY
Steps
-45; -469; 1050; 95
SECONDARY
Peak Expiratory Flow (PEF)
14.2; 27.4; 28.7; 24.1
SECONDARY
Forced Vital Capacity (FVC)
0.17; 0.18; 0.25; 0.23
SECONDARY
The Forced Expiratory Volume in 1 Second (FEV1)
0.14; 0.11; 0.19; 0.15
SECONDARY
Whole-Body Phase Angle
0.04; -0.1; -0.02; -0.12

Summary

The purpose of this study is to confirm the effectiveness of a mobile messenger-based home tele-rehabilitation protocol in patients who have undergone lung resection surgery. By analyzing the difference from the existing postoperative pulmonary rehabilitation, the investigators would like to propose a new pulmonary tele-rehabilitation protocol.

Eligibility Criteria

Inclusion Criteria

  • A person who is suspected of lung cancer and is scheduled to undergo a thoracoscopic lung resection surgery.
  • men and women the age ≥65 years.
  • A person who understands the course of the clinical trial and signs the informed consent form.

Exclusion Criteria

  • Patients whose activity is restricted due to other diseases (e.g. osteoarthritis, spinal disease, cerebral infarction, etc.)
  • Patients who cannot test bioimpedance analysis due to the insertion of artificial pacemakers and defibrillators
  • A person who has difficulty judging himself/herself due to dementia, etc
  • Those enrolled in other clinical trials
  • A person deemed inappropriate to participate in this clinical trial under the judgement of the investigator.
  • A person who cannot use mobile messenger
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05435885). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search